SYNC - SYNCONA - Share Chat

Syncona is a leading UK-based life sciences venture capital firm, listed on the London Stock Exchange (LSE: SYNC). Operating with a unique evergreen capital structure, it specialises in founding, building, and funding a portfolio of innovative, globally competitive companies. Syncona’s strategy focuses on identifying groundbreaking science, primarily from top academic institutions, to address areas of high unmet medical need.

The firm provides significant capital and strategic support, partnering with exceptional scientists to translate cutting-edge research into successful clinical-stage businesses, particularly in areas like gene and cell therapies. Syncona aims to create long-term value by nurturing these companies through their development, ultimately seeking exits that deliver strong returns.